MK-686

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-686, covering 2014-12-24 to 2014-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006) [Phase 2]

See pricing